Adriamycin
| CAS No. | 23214-92-8 | Cat. No. | BCP37549 |
| Name | Adriamycin | ||
| Synonyms | Doxorubicin;Adriablastin; | ||
| Formula | C27H29NO11 | M. Wt | 543.52 |
| Description | Adriamycin is an anthracycline antibiotic with antineoplastic activity. Approved API for cancer therapeutic use is doxorubicin HCl. Doxorubicin, isolated from the bacterium Streptomyces peucetius var. caesius, is the hydroxylated congener of daunorubicin. Doxorubicin intercalates between base pairs in the DNA helix, thereby preventing DNA replication and ultimately inhibiting protein synthesis. |
|
Graphene quantum dots mediated magnetic chitosan drug delivery nanosystems for targeting synergistic photothermal-chemotherapy of hepatocellular carcinoma
Publications Citing of Biochempartner's Adriamycin(CAS:23214-92-8) |
|
Graphene quantum dots mediated magnetic chitosan drug delivery nanosystems for targeting synergistic photothermal-chemotherapy of hepatocellular carcinoma
Publications Citing of Biochempartner's Adriamycin(CAS:23214-92-8) |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.